Supernus Pharmaceuticals, Inc. (SUPN)
NASDAQ·Healthcare·Drug Manufacturers - Specialty & Generic
$26.43
+1.03%
Mkt Cap $2.11B
Analyst Ratings
Buy
4
Hold
0
Sell
0
Price Target (10 analysts)
$57.60
Range $40.00 – $65.00
Implied Upside
+117.9%
Consensus $57.60 vs current $26.43